ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
49 announcements
CARE Ratings allotted 16,133 equity shares to employees on exercising ESOP options under the CARE ESOS 2020. Paid-up capital rises to Rs.30,14,87,450 across 3,01,48,745 shares.
Q2 FY27 consolidated operating income Rs 164.13 Cr (+20% YoY), PAT Rs 72.37 Cr (+26%), PAT margin 40%. Ratings business drove growth; no explicit guidance given.
CARE Ratings Limited appointed Mr. Jatindar Pal Singh Bajaj as a Non-Executive Non-Independent Director, effective October 29, 2026.
CARE Ratings Limited declared an interim dividend of ₹10 per equity share for the financial year 2026-2027. The record date is set for November 6, 2026.
CARE Ratings reported strong Q2 and H1 FY27 operating income and profit growth. The board also declared an interim dividend of Rs 10 per share.
CARE Ratings Ltd reported revenue from operations of ₹164.1 Cr (+20.3% YoY) and net profit of ₹72.4 Cr (+26.6% YoY) for Q2 FY27.
CARE Ratings executed SPAs to sell 9.90% stakes each in subsidiary CareEdge Global IFSC to SBI and NSE IFSC. CARE will retain 80.20% post-closing.
CARE Ratings Ltd has filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulatory requirements.
CARE Ratings Limited intimated a board meeting scheduled for 29 October 2026 to consider unaudited half-yearly financial results and an interim dividend. No figures or decisions have been made yet.
CARE Ratings Limited allotted 14,200 equity shares to employees following the exercise of options under its Employee Stock Option Scheme 2020.
CARE Ratings Q1 FY27 presentation highlights 18.9% consolidated revenue growth and 24.6% PAT growth. Expansion into global sovereign ratings and ESG services drives non-ratings momentum.
CARE Ratings has allotted 24,500 equity shares to employees following the exercise of options under its Employee Stock Option Scheme 2020.
CARE Ratings (CareEdge) reported strong Q1 FY27 results with consolidated operating income of Rs. 111.68 Cr, up 18.9% YoY, driven by growth in both Ratings and Non-Ratings segments.
CARE Ratings Limited reported its Q1 FY27 results, highlighting strong standalone revenue growth of 16.5% YoY and consolidated revenue growth of 18.9% YoY.
CARE Ratings Ltd reported revenue from operations of ₹111.7 Cr (+19.0% YoY) and net profit of ₹33 Cr (+24.5% YoY) for Q1 FY27.
CARE Ratings Limited allotted 6,766 equity shares to employees upon the exercise of stock options under its ESOP scheme.
CARE Ratings will hold a board meeting on August 7, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
CARE Ratings Ltd filed its shareholding pattern for the quarter ending June 30, 2026, detailing holdings across various investor categories. No monetary transactions were disclosed.
CARE Ratings allotted 26,733 shares to employees under its ESOP 2020. Paid-up capital rose to Rs.30.08 crore from Rs.30.06 crore.
CARE Ratings held its 33rd AGM, approving financials and declaring a final dividend of Rs.14 per share. All resolutions passed with requisite majority.
CARE Ratings Limited appointed Mr. Sanjay Agarwal as Chief Risk Officer effective August 1, 2026. The appointment adds seasoned risk expertise to the senior management team.
CARE Ratings delivered strong FY26 performance with consolidated revenue up 18% and PAT up 24%. Strategy focuses on scaling global rating entities and non-rating AI-driven analytics.
CARE Ratings delivered strong FY26 performance with 18% consolidated revenue growth and 24% PAT growth, driven by ratings and non-ratings segments.
CARE Ratings Limited allotted 11,250 equity shares under its ESOP scheme. The allotment increased the company's total paid-up share capital to ₹30.06 Crore.
CARE Ratings allotted 11,250 equity shares under its ESOP scheme. This increases paid-up capital and reflects employee stock option exercises.
CARE Ratings Limited has scheduled its Annual General Meeting for July 3, 2026. Key agenda items include adopting financial statements and declaring a final dividend.
CARE Ratings Limited dispatched its FY 2025-26 Annual Report and 33rd AGM notice. The meeting is scheduled for July 3, 2026, via video conferencing.
Madras High Court vacated an asset alienation injunction against CARE Ratings after compliance. This resolution removes prior legal restraints on the company's asset operations.
CARE Ratings delivered strong Q4FY26 results with consolidated revenue growing 19% YoY to ₹130.67 Cr. Strategy focuses on AI adoption (60% staff usage) and expanding global sovereign and ESG rating services.
CARE Ratings delivered strong FY26 performance with consolidated revenue growth of 18% and PAT growth of 24%. Strategy focuses on scaling global ratings and AI-driven analytics.